Teruhiko Tamaya

Author PubWeight™ 44.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Coexpression of Gas6/Axl in human ovarian cancers. Oncology 2004 1.23
2 Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci 2004 1.03
3 Microbiology of Bartholin's gland abscess in Japan. J Clin Microbiol 2005 0.97
4 Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent. Biol Pharm Bull 2004 0.96
5 Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer 2009 0.96
6 Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women. Steroids 2003 0.94
7 Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers. J Steroid Biochem Mol Biol 2007 0.94
8 Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers. Oncology 2004 0.93
9 Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers. J Biomed Sci 2007 0.93
10 Clinical implication of estrogen-related receptor (ERR) expression in ovarian cancers. J Steroid Biochem Mol Biol 2007 0.90
11 Penetration of ravuconazole, a new triazole antifungal, into rat tissues. Chemotherapy 2002 0.89
12 Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers. Gynecol Oncol 2009 0.87
13 Sex steroid-dependent angiogenesis in uterine endometrial cancers. J Steroid Biochem Mol Biol 2005 0.86
14 Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126. Int J Oncol 2005 0.84
15 Translocation of lysophosphatidic acid phosphatase in response to gonadotropin-releasing hormone to the plasma membrane in ovarian cancer cell. Am J Obstet Gynecol 2004 0.83
16 Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers. Oncology 2008 0.82
17 Estrogen-related receptor expression in placenta throughout gestation. J Steroid Biochem Mol Biol 2005 0.82
18 Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers. Cancer Sci 2003 0.82
19 Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. Gynecol Oncol 2004 0.82
20 Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers. Cancer Lett 2006 0.82
21 Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage. Gynecol Obstet Invest 2006 0.81
22 Anti-tumor effects of herbal medicines on endometrial carcinomas via estrogen receptor-alpha-related mechanism. Oncol Rep 2006 0.81
23 Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers. J Biomed Sci 2006 0.80
24 Uterine contractions might increase heart preload in the recipient fetus in early-onset twin-twin transfusion syndrome: an ultrasound assessment. Prenat Diagn 2004 0.80
25 Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers. Oncology 2002 0.80
26 Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer. Oncol Rep 2006 0.80
27 Penetration into and exposure of cefozopran in pelvic retroperitoneal space exudate. J Infect Chemother 2008 0.80
28 [Two cases of Bartholin's gland abscesses caused by Streptococcus pneumoniae and Haemophilus influenzae]. Jpn J Antibiot 2005 0.80
29 Expression of ETS-1 related to angiogenesis in uterine endometrium during the menstrual cycle. J Biomed Sci 2003 0.79
30 Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy. J Obstet Gynaecol 2003 0.79
31 Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers. Oncology 2007 0.78
32 PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells. Oncol Rep 2006 0.78
33 [Prevalence and treatment of pharyngeal Chlamydia trachomatis infections]. Jpn J Antibiot 2006 0.78
34 Leptin as an acute stress-related hormone in the fetoplacental circulation. Obstet Gynecol 2002 0.78
35 Intratumoral level of gonadotropin-releasing hormone in ovarian and endometrial cancers. Oncol Rep 2002 0.78
36 Role of inhibitor of DNA binding-1 protein is related to angiogenesis in the tumor advancement of uterine endometrial cancers. Exp Ther Med 2010 0.78
37 Intravaginal bacterial flora in patients with uterine cervical cancer. High incidence of detection of Gardnerella vaginalis. J Infect Chemother 1999 0.78
38 Clinical efficacy of clarithromycin against uterine cervical and pharyngeal Chlamydia trachomatis and the sensitivity of polymerase chain reaction to detect C. trachomatis at various time points after treatment. J Infect Chemother 2003 0.78
39 Cavernous lymphangioma arising from uterine corpus. Gynecol Oncol 2003 0.77
40 MRI during pregnancy. J Perinat Med 2003 0.77
41 Membrane-associated serine/threonine protein phosphatase in endometrial cancer. Am J Obstet Gynecol 2003 0.77
42 Independent action of serine/threonine protein phosphatase in ovarian cancer plasma membrane and cytosol during gonadotropin-releasing hormone stimulation. Oncol Rep 2003 0.77
43 Plausible linkage of hypoxia inducible factor-1alpha in uterine cervical cancer. Cancer Sci 2006 0.77
44 Shimotsu-to is the agent in Juzen-taiho-to responsible for the prevention of endometrial carcinogenesis in mice. Cancer Lett 2002 0.77
45 Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers. Oncol Rep 2007 0.77
46 Association of cellular apoptosis with anti-tumor effects of the Chinese herbal complex in endocrine-resistant cancer cell line. Cancer Detect Prev 2003 0.76
47 [Anaerobic abscess]. Nihon Rinsho 2003 0.76
48 In vitro stimulation of granulosa cells by a combination of different active ingredients of unkei-to. Am J Chin Med 2004 0.76
49 Inhibitory effects of Hochu-ekki-to on endometrial carcinogenesis induced by N-methyl-N-nitrosourea and 17beta-estradiol in mice. Oncol Rep 2006 0.76
50 Prognostic implications of cimetidine on advanced serous ovarian carcinoma related to cyclooxygenase-2 expression. Mol Med Rep 2011 0.76
51 Expression of E26 transformation specific (ETS-1) related to angiogenesis in ovarian endometriosis. Fertil Steril 2004 0.76
52 Expression of estrogen receptor beta exon-deleted variant mRNAs in ovary and uterine endometrium. J Steroid Biochem Mol Biol 2003 0.76
53 Divalent hammerhead ribozyme targeting template region of human telomerase RNA has potent cleavage activity, but less inhibitory activity on telomerase. Arch Biochem Biophys 2002 0.75
54 Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers. BMC Cancer 2008 0.75
55 In vitro and in vivo antibacterial activities of telithromycin. Chemotherapy 2003 0.75
56 Preventive effects of glycyrrhizin on estrogen-related endometrial carcinogenesis in mice. Oncol Rep 2007 0.75
57 Evidence for hormone-responsive cleavage of gonadotropin-releasing hormone by the plasma membrane of ovarian cancer cells. Int J Oncol 2002 0.75
58 Effects of various steroids on platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA expression in uterine endometrial cancer cells. J Steroid Biochem Mol Biol 2003 0.75
59 Advanced indications for gonadotropin-releasing hormone (GnRH) analogues in gynecological oncology (review). Int J Oncol 2003 0.75
60 Evidence for tight coupling of Gi protein-mediated lysophosphatidic acid receptor to stimulated cytokine production in ovarian cancer cell. Am J Obstet Gynecol 2004 0.75
61 Tuboovarian abscess caused by Candida glabrata in a febrile neutropenic patient. J Infect Chemother 2003 0.75
62 Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice. J Antimicrob Chemother 2005 0.75
63 Gonadotropin-releasing hormone retards doxorubicin-induced apoptosis and serine/threonine phosphatase inhibition in ovarian cancer cells. Oncol Rep 2005 0.75
64 Penetration of oral telithromycin into female genital tissues. J Infect Chemother 2003 0.75
65 [Clinical investigation on administration method of gatifloxacin based on PK/PD theory]. Jpn J Antibiot 2006 0.75
66 Pharmacokinetics of single-dose intravenous ciprofloxacin in blood and ascites of patients with pelvic peritonitis. J Infect Chemother 2003 0.75
67 Puerperal intrauterine infection caused by Edwardsiella tarda. J Infect Chemother 2003 0.75
68 [Effectiveness of switch therapy for peritonitis]. Jpn J Antibiot 2007 0.75
69 Topical vidarabine or 5-fluorouracil treatment against persistent HPV in genital (pre)cancerous lesions. Oncol Rep 2003 0.75
70 Quantitative analysis of estrogen receptor proteins in rat ovary. J Steroid Biochem Mol Biol 2005 0.75
71 [Investigation on administration method of carbapenems]. Jpn J Antibiot 2002 0.75
72 Inhibitory effects of toremifene on N-methyl-N-nitrosourea and estradiol-17beta-induced endometrial carcinogenesis in mice. Jpn J Cancer Res 2002 0.75
73 Nosocomial infectious potency of imipenem-resistant Pseudomonas aeruginosa isolated from obstetric and gynecologic infections. J Infect Chemother 2003 0.75